Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Aug;88(8):715-8.
doi: 10.1136/adc.88.8.715.

Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis

N M Byrne  1 , P M Keavey, J D Perry, F K Gould, D A Spencer
Affiliations
Clinical Trial

Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis

N M Byrne et al. Arch Dis Child. 2003 Aug.

Abstract

Aim: To examine the effectiveness of delivery of nebulised colistin by the HaloLite nebuliser compared to the Pari LC Plus in patients with cystic fibrosis.

Methods: Randomised crossover trial of 15 patients aged >6 years. Inhalation of one mega unit of colistin in 3 ml diluent, labelled with technetium-99m DTPA, was used to assess lung deposition. The Pari was nebulised to dryness and one button press of the HaloLite was completed. Following a seven day washout period, patients inhaled colistin twice daily for seven days through the first device. Sputum specimens were analysed for colistin levels and pseudomonas load. This procedure was repeated with the alternative device.

Results: Lung uptake of radiolabelled colistin was significantly higher with the Pari. However, lung uptake calculated as a percentage of the amount of drug used was significantly higher for the HaloLite. Time to nebulise was significantly shorter with the HaloLite. Sputum levels of colistin were higher following use of the Pari; this was close to significance.

Conclusion: The manufacturer's recommended dosages for nebulising antibiotics with a HaloLite result in a lower delivery than patients receive when using a Pari nebuliser. The concept of adaptive aerosol delivery has several theoretical advantages but the recommended doses for the HaloLite need to be modified in order to improve effectiveness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Lung deposition of radiolabelled colistin for each subject following use of the HaloLite and Pari LC Plus nebulisers.
Figure 2
Figure 2
Colistin levels in sputum at one hour after use of the HaloLite and Pari LC Plus nebulisers.
See this image and copyright information in PMC

Comment in

References

    1. Arch Dis Child. 2001 May;84(5):432-3 - PubMed
    1. Lancet. 1981 Nov 21;2(8256):1137-9 - PubMed
    1. Arch Dis Child. 1982 Aug;57(8):582-6 - PubMed
    1. Lancet. 1985 Apr 13;1(8433):865 - PubMed
    1. Eur Respir J. 1990 Nov;3(10):1114-6 - PubMed

MeSH terms